Conditioned medium of H9c2 triggers VEGF dependent angiogenesis by activation of p38/pSTAT3 pathways in placenta derived stem cells for cardiac repair.

[1]  M. S. Oliveira,et al.  Placental-derived stem cells: Culture, differentiation and challenges. , 2015, World journal of stem cells.

[2]  B. Hurwitz,et al.  Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells , 2015, EBioMedicine.

[3]  E. Marbán,et al.  c-kit+ Cells Minimally Contribute Cardiomyocytes to the Heart , 2014, Nature.

[4]  Xin Li,et al.  Quantitative profiling of the rat heart myoblast secretome reveals differential responses to hypoxia and re-oxygenation stress. , 2014, Journal of proteomics.

[5]  B. Friguet,et al.  Proteome Modulation in H9c2 Cardiac Cells by microRNAs miR-378 and miR-378* , 2013, Molecular & Cellular Proteomics.

[6]  Ciro Indolfi,et al.  Adult c-kitpos Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair , 2013, Cell.

[7]  C. Bai,et al.  Surface Expression of HLA-G is Involved in Mediating Immunomodulatory Effects of Placenta-Derived Multipotent Cells (PDMCs) towards Natural Killer Lymphocytes , 2011, Cell transplantation.

[8]  J. Hare,et al.  Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. , 2011, Circulation research.

[9]  M. Gnecchi,et al.  Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. , 2011, Journal of molecular and cellular cardiology.

[10]  S. Dimmeler,et al.  Mesenchymal Stem Cells Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease , 2011 .

[11]  J. Forrester,et al.  Review Article: Current Status of Myocardial Regeneration: New Cell Sources and New Strategies , 2010, Journal of cardiovascular pharmacology and therapeutics.

[12]  Wei Liu,et al.  The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. , 2010, Rejuvenation research.

[13]  M. Soonpaa,et al.  Cardiomyogenic Potential of C-Kit+–Expressing Cells Derived From Neonatal and Adult Mouse Hearts , 2010, Circulation.

[14]  A. Bayés‐Genís,et al.  Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells , 2010, Basic Research in Cardiology.

[15]  O. Parolini,et al.  Amniotic Mesenchymal Tissue Cells Inhibit Dendritic Cell Differentiation of Peripheral Blood and Amnion Resident Monocytes , 2009, Cell transplantation.

[16]  K. Atkinson,et al.  Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. , 2008, Stem cells and development.

[17]  E. Martin-Rendon,et al.  5‐Azacytidine‐treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies , 2008, Vox sanguinis.

[18]  K. Djinović-Carugo,et al.  α-Actinin structure and regulation , 2008, Cellular and Molecular Life Sciences.

[19]  E. Jones,et al.  Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies , 2008, Mechanisms of Ageing and Development.

[20]  Mark A Sussman.  "AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation. , 2007, Trends in cardiovascular medicine.

[21]  M. Yen,et al.  Placenta‐Derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon‐γ , 2006, Stem cells.

[22]  Wei Huang,et al.  Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells , 2006, Cell biology international.

[23]  K. Ohta,et al.  Vascular Endothelial Growth Factor–Expressing Mesenchymal Stem Cell Transplantation for the Treatment of Acute Myocardial Infarction , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[24]  K. Walsh,et al.  AMP-Activated Protein Kinase Signaling Stimulates VEGF Expression and Angiogenesis in Skeletal Muscle , 2005, Circulation research.

[25]  M. Yen,et al.  Isolation of Multipotent Cells from Human Term Placenta , 2005, Stem cells.

[26]  O. Carpén,et al.  Alpha-actinin revisited: a fresh look at an old player. , 2004, Cell motility and the cytoskeleton.

[27]  Stefanie Dimmeler,et al.  Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease , 2004, Circulation.

[28]  J. Degen,et al.  Functional role of connexin43 gap junction channels in adult mouse heart assessed by inducible gene deletion. , 2004, Journal of molecular and cellular cardiology.

[29]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[30]  Dominique Shum-Tim,et al.  Mobilization and homing of bone marrow stromal cells in myocardial infarction. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[31]  J. Abbruzzese,et al.  Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis , 2003, Oncogene.

[32]  G. Kollias,et al.  Myocyte-dependent Regulation of Endothelial Cell Syndecan-4 Expression , 1999, The Journal of Biological Chemistry.

[33]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.